BMI Evaluation: Placebo and Active Comparator Trial of Olanzapine Zydis Pills Used Sublingually (PLATYPUS)
BMI Evaluation: Placebo and Active Comparator Trial of Olanzapine Zydis Pills Used Sublingually (PLATYPUS)
This study is testing if under the tongue olanzapine for schizophrenia, related psychosis, schizoaffective disorder or bipolar disorder will have less weight gain than olanzapine that is swallowed, in patients who are already gaining weight on olanzapine.
Inclusion Criteria (Patients must):
Exclusion Criteria (Patients must NOT):
Escondido, California 92025, United States
Garden Grove, California 92845, United States
National City, California 91950, United States
Orange, California 92868, United States
Atlanta, Georgia 30308, United States
Las Vegas, Nevada 89102, United States
Staten Island, New York 10312, United States
Penticton, British Columbia V2A 4M4, Canada
Winnipeg, Manitoba R3E 3N4, Canada
Dartmouth, Nova Scotia B2Y 3Z9, Canada
Halifax, Nova Scotia B3H 2E2, Canada
Sydney, Nova Scotia B1S 2E8, Canada
Chatham, Ontario N7L 1B7, Canada
Greater Sudbury, Ontario P3C 1T4, Canada
Kingston, Ontario K7L 4X3, Canada
Windsor, Ontario N9C 3Z4, Canada
Sherbrooke, Quebec J1G 1W4, Canada
Mexico City, 01030, Mexico
Amersfoort, 3816 CP, Netherlands
Rotterdam, 3015 GD, Netherlands